Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 crawled time : 21:03 save search
Vertex Announces FDA Fast Track Designation and Initiation of a Phase 1/2 Clinical Trial for VX-880, a Novel Investigational Cell Therapy for the Treatment of Type 1 Diabetes
Published: 2021-03-10 (Crawled : 21:03) - biospace.com/
VRTX | $400.07 1.47% 1.45% 1.3M
|
Health Technology
|
| O: 1.52%
H: 0.19%
C: -1.39%
diabetes treatment fda fda fast track phase 1 therapy trial phase 3 phase 2 fast track fast track designation
Amicus’ AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase 3 PROPEL Study
Published: 2021-02-11 (Crawled : 21:03) - globenewswire.com
FOLD F | $10.83 2.07% 2.03% 3.7M
|
Health Technology
|
| O: -24.7%
H: 1.74%
C: -10.88%
disease respiratory phase 3
Agios Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused
Published: 2021-01-26 (Crawled : 21:03) - globenewswire.com
AGIO | $30.21 2.3% 2.25% 840K
|
Health Technology
|
| O: 0.62%
H: 0.48%
C: -5.17%
phase 3 trial
Fate Therapeutics Reports Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma
Published: 2020-12-04 (Crawled : 21:03) - globenewswire.com
FATE | News | $4.785 -0.1% -0.21% 1.4M
|
Health Technology
| Email alert
Add to watchlist
positive phase 3 phase 1 phase 2 t-cell
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.